| Coronary adventitial and perivascular adipose tissue inflammation in patients with vasospastic angina K Ohyama, Y Matsumoto, K Takanami, H Ota, K Nishimiya, J Sugisawa, ... Journal of the American College of Cardiology 71 (4), 414-425, 2018 | 166 | 2018 |
| Co-existence of carotid artery disease, renal artery stenosis, and lower extremity peripheral arterial disease in patients with coronary artery disease Y Imori, T Akasaka, T Ochiai, K Oyama, K Tobita, K Shishido, Y Nomura, ... The American journal of cardiology 113 (1), 30-35, 2014 | 97 | 2014 |
| Association of Coronary Perivascular Adipose Tissue Inflammation and Drug-Eluting Stent–Induced Coronary Hyperconstricting Responses in Pigs: 18F … K Ohyama, Y Matsumoto, H Amamizu, H Uzuka, K Nishimiya, ... Arteriosclerosis, thrombosis, and vascular biology 37 (9), 1757-1764, 2017 | 42 | 2017 |
| Enhanced adventitial vasa vasorum formation in patients with vasospastic angina: assessment with OFDI K Nishimiya, Y Matsumoto, J Takahashi, H Uzuka, H Wang, R Tsuburaya, ... Journal of the American College of Cardiology 67 (5), 598-600, 2016 | 40 | 2016 |
| Obesity and effects of dapagliflozin on cardiovascular and renal outcomes in patients with type 2 diabetes mellitus in the DECLARE–TIMI 58 trial K Oyama, I Raz, A Cahn, J Kuder, SA Murphy, DL Bhatt, LA Leiter, ... European heart journal 43 (31), 2958-2967, 2022 | 37 | 2022 |
| Prognostic links between OCT-delineated coronary morphologies and coronary functional abnormalities in patients with INOCA K Nishimiya, A Suda, K Fukui, K Hao, J Takahashi, Y Matsumoto, ... Cardiovascular Interventions 14 (6), 606-618, 2021 | 32 | 2021 |
| Effect of evolocumab on complex coronary disease requiring revascularization K Oyama, RHM Furtado, A Fagundes Jr, TA Zelniker, M Tang, J Kuder, ... Journal of the American College of Cardiology 77 (3), 259-267, 2021 | 32 | 2021 |
| Increased coronary perivascular adipose tissue volume in patients with vasospastic angina K Ohyama, Y Matsumoto, K Nishimiya, K Hao, R Tsuburaya, H Ota, ... Circulation Journal 80 (7), 1653-1656, 2016 | 32 | 2016 |
| Accuracy of Optical Frequency Domain Imaging for Evaluation of Coronary Adventitial Vasa Vasorum Formation After Stent Implantation in Pigs and Humans–A Validation Study– K Nishimiya, Y Matsumoto, H Uzuka, K Oyama, A Tanaka, A Taruya, ... Circulation Journal 79 (6), 1323-1331, 2015 | 32 | 2015 |
| Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trial K Oyama, RP Giugliano, DD Berg, CT Ruff, P Jarolim, M Tang, SA Murphy, ... European Heart Journal 42 (17), 1698-1706, 2021 | 31 | 2021 |
| Effect of evolocumab on acute arterial events across all vascular territories: results from the FOURIER trial K Oyama, RP Giugliano, M Tang, MP Bonaca, JL Saver, SA Murphy, ... European Heart Journal 42 (47), 4821-4829, 2021 | 29 | 2021 |
| Treatment strategies of acute myocardial infarction: updates on revascularization, pharmacological therapy, and beyond Y Saito, K Oyama, K Tsujita, S Yasuda, Y Kobayashi Journal of Cardiology 81 (2), 168-178, 2023 | 28 | 2023 |
| Baseline low-density lipoprotein cholesterol and clinical outcomes of combining ezetimibe with statin therapy in IMPROVE-IT K Oyama, RP Giugliano, MA Blazing, JG Park, AM Tershakovec, ... Journal of the American College of Cardiology 78 (15), 1499-1507, 2021 | 26 | 2021 |
| Absence of adventitial vasa vasorum formation at the coronary segment with myocardial bridge-An optical coherence tomography study K Nishimiya, Y Matsumoto, H Wang, Z Piao, K Ohyama, H Uzuka, K Hao, ... International Journal of Cardiology 250, 275-277, 2018 | 25 | 2018 |
| Efficacy and Safety of Long-Term Evolocumab Use Among Asian Subjects―A Subgroup Analysis of the Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With … AC Keech, K Oyama, PS Sever, M Tang, SA Murphy, A Hirayama, C Lu, ... Circulation Journal 85 (11), 2063-2070, 2021 | 16 | 2021 |
| Focal Vasa Vasorum Formation in Patients With Focal Coronary Vasospasm–An Optical Frequency Domain Imaging Study– K Nishimiya, Y Matsumoto, H Uzuka, K Ohyama, K Hao, R Tsuburaya, ... Circulation Journal 80 (10), 2252-2254, 2016 | 16 | 2016 |
| Renal Denervation Suppresses Coronary Hyperconstricting Responses After Drug-Eluting Stent Implantation in Pigs In Vivo Through the Kidney–Brain–Heart Axis H Uzuka, Y Matsumoto, K Nishimiya, K Ohyama, H Suzuki, H Amamizu, ... Arteriosclerosis, Thrombosis, and Vascular Biology 37 (10), 1869-1880, 2017 | 15 | 2017 |
| Effect of evolocumab in patients with prior percutaneous coronary intervention RHM Furtado, AA Fagundes Jr, K Oyama, TA Zelniker, M Tang, JF Kuder, ... Circulation: Cardiovascular Interventions 15 (3), e011382, 2022 | 14 | 2022 |
| Cardiac Lymphatic Dysfunction Causes Drug-Eluting Stent–Induced Coronary Hyperconstricting Responses in Pigs In Vivo H Amamizu, Y Matsumoto, S Morosawa, K Ohyama, H Uzuka, M Hirano, ... Arteriosclerosis, Thrombosis, and Vascular Biology 39 (4), 741-753, 2019 | 11 | 2019 |
| Coronary artery spasm and perivascular adipose tissue inflammation: insights from translational imaging research K Ohyama, Y Matsumoto, H Shimokawa European Cardiology Review 14 (1), 6, 2019 | 10 | 2019 |
